Lista de obras - Martina Biggioggero - Dominio Público Uruguay

Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy

artículo científico publicado en 2004

Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome

artículo científico publicado en 2013

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

artículo científico publicado en 2014

IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors

artículo científico publicado en 2007

Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.

artículo científico publicado en 2007

In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants

artículo científico publicado en 2005

Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?

artículo científico publicado en 2014

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

artículo científico publicado en 2017

Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study

artículo científico publicado en 2015

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences

artículo científico publicado en 2017

Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients

scientific article published on 19 June 2020

Sarilumab: patient-reported outcomes in rheumatoid arthritis

artículo científico publicado en 2018

Sex and Management of Rheumatoid Arthritis

artículo científico publicado en 2018

Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases

artículo científico publicado en 2013

Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies

artículo científico publicado en 2014

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

artículo científico publicado en 2015

The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future

artículo científico publicado en 2018

The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors

artículo científico publicado en 2019

The challenging definition of naïve patient for biological drug use.

artículo científico publicado en 2015

The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis

artículo científico publicado en 2013

The geoepidemiology of the antiphospholipid antibody syndrome

artículo científico publicado en 2009

The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives

artículo científico publicado en 2017

The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials

artículo científico publicado en 2012

The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry.

artículo científico publicado en 2018

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

article

Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs

artículo científico publicado en 2014

Type I interferon therapy and its role in autoimmunity

artículo científico publicado en 2010

Updating on the pathogenesis of systemic lupus erythematosus

artículo científico publicado en 2010

Lista de obras de Martina Biggioggero

Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy

Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors

Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.

In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants

Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences

Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients

Sarilumab: patient-reported outcomes in rheumatoid arthritis

Sex and Management of Rheumatoid Arthritis

Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases

Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future

The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors

The challenging definition of naïve patient for biological drug use.

The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis

The geoepidemiology of the antiphospholipid antibody syndrome

The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives

The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials

The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry.

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs

Type I interferon therapy and its role in autoimmunity

Updating on the pathogenesis of systemic lupus erythematosus